Side effects, quality-of-life issues, and trade-offs: the patient perspective.

Journal of the National Cancer Institute. Monographs

Volumn , Issue 30, 2001, Pages 125-129

  Langer, A S ^a  

^a Natl Alliance of Breast Carcer Org   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; MAMMOGRAPHY; PATIENT ADVOCACY; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK ASSESSMENT;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; FEMALE; HUMANS; MAMMOGRAPHY; PATIENT ADVOCACY; PATIENT EDUCATION; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 0035755628     PISSN: 10526773     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jncimonographs.a003449     Document Type: Article

References (0)